Class II
Drug Recall: Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 62175-322-46
Lannett Company Inc. · October 10, 2025
Reason for Recall
Failed Dissolution Specifications
Distribution
Nationwide in the USA
States Affected
NATIONWIDE
Quantity Affected
46,848 90-count bottles
Source: FDA (openFDA Drug Enforcement)
Recall number: D-0096-2026
Status: ongoing
SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.